Wall Street’s top analysts predicted Monday the same as Nvidia
Here are the biggest comments on Wall Street on Monday: TD Cowen reiterates Nvidia buyout TD said Nvidia remains the top choice at the company. “NVIDIA is our team’s top choice, far and away the technology leader in AI.” Mizuho reiterates Advanced Micro Devices had better results Mizuho said it remained stock after last week’s AI day. “With AMD gaining server market share, PC recovery potential and upcoming AI products, we see a base PT price of $19…” Mizuho echoes Broadcom in outperforming Mizuho raised target Target stock price to 220 USD/share from 190 USD. “AVGO OpenAI AI Chip Win Could Have >$16B Potential in 2H25-26E.” Goldman Sachs upgrades Ibotta to buy from neutral. Goldman Sachs reiterates Alphabet’s buy. Goldman lowered its stock price target to $208/share from $217 due to many headwinds for Alphabet. “For the current operating environment, we see a solid/stable environment for direct response advertising, a stable environment for brand advertising, although weaker than industry trends and media consumption continues to grow for short/long-form video content with short-form video monetization growth slowing but acting as a tailwind over the next 12-18 months.” Wells Fargo upgrades Flutter to overweight from balanced Wells said investors should buy the gambling company’s shares on a dip. “We’re upgrading FLUT to OW, which with our new $295 PT means a 34% increase.” Truist downgrades Amgen to retain purchase Truist said in downgrading Amgen that it sees increased competition for the biotech company. “…pipeline competition reduces upside potential. Downgrade to Hold, PT $333.” Morgan Stanley downgrades Caterpillar to underweight from equal weight Morgan Stanley said it sees “increasing inventory drawdown risks” in the company’s construction industry segment. “Downgraded CAT to Underweight due to increased pressure in CI [construction industries] from potential inventory reductions.” UBS initiates Surgical Partners on purchase UBS said the outpatient surgery company has “attractive organic growth.” “We initiate coverage of Surgical Partners with a Buy rating and $38 price target.” Piper Sandler echoed Tesla when overweight Piper said it remained overweight ahead of Tesla’s earnings on Oct. 23: “We were hoping that the The launch of robot taxis would give reason to increase estimates – and optimism is fading on this issue – but otherwise, there is no reason at all. needed to cut estimates as we have always assumed that full self-driving (FSD) software revenues would not start to increase until 2027/2028.” UBS initiated Netstreit in buying UBS said the company’s shares real estate investment firm is undervalued. “We recommend buying NTST as we expect to drive external growth at an overweight valuation.” Goldman downgraded the auto parts retailer due to “slow growth.” “We downgrade AZO to Sell from Buy as we reposition our stock rating distribution in favor of the companies.” greater exposure to discretionary commodities.” Evercore ISI adds Apple to its tactical outperform list. Evercore said it is aiming for earnings growth later this month. “Apple sentiment has turned sour more bearish in recent weeks and we think buyers’ expectations may be lower than current consensus estimates. Against this backdrop, we expect Apple to deliver results in line with estimates For now, this should help the stock move higher.” .” JMP downgrades Duolingo’s rating to market perform from market outperform JMP downgraded the language app company primarily based on valuation. “We are downgrading Duolingo from Market Outperform to Market Performer after shares rose 78% since reporting 2Q24 earnings, 5% above our previous price target. We and currently trade at 27 times and 19 times our 2026 and 2027 “Blue Sky” EBITDA, respectively.” Baird downgrades KeyCorp to neutral from outperform, Baird said More balanced profits for regional banks. ” KEY – downgrade to Neutral, more balanced risk/reward here following SPX’s notable outperformance since our March 2023 upgrade.” Jefferies Upgrades AptarGroup to Stop Buying Jefferies said the pharmaceutical company’s shares are bullish. “With solid execution, ATR is up ~30% YTD, but with a strong new product pipeline such as the GLP-1 drug delivery system, for OTC [over the counter] Narcan and for Neffy (epinephrine nasal spray), we estimate the Pharma segment to lead the overall EBITDA CAGR 8.5% through 2026.” Piper Sandler upgrades SentinelOne to overweight from neutral Piper Sandler said they see a series of positive catalysts ahead for the networking company “We are upgrading shares of S as we see multiple catalysts driving the stock higher into year-end…” Wells Fargo downgraded VF Corp to underweight from equal weight. Wells said in downgrading VF Corp that the owner of brands like Vans has shares now fully “Downgraded to UW and down PT down to 15 USD. The stock has risen in price and valuations appear to be much higher than they actually are. Wells Fargo downgrades Canada Goose from overweight to underweight Wells said it sees too many macro concerns about China for the outerwear company. ” GOOS has placed China at the center of its DTC expansion plan (now accounting for 40% of stores and > 30% of sales), leaving the brand too exposed to volatile macro, which has gotten worse over the past year.” Goldman Sachs downgraded AppLovin to neutral from buy. The company said it sees a more balanced risk/reward for software publishers. “Compared to the share price of $143, we now see a more balanced risk/reward for the stock than current levels. Since being added to the Buy List on April 19, 2022, APP stock is up +192% vs. SPX +30%.” Goldman Sachs Upgrades Ibotta to Neutral Buy Goldman said it likes the growth opportunities for the mobile technology company. “For IBTA, we see an attractive risk/reward as we view the current valuation as underestimating IBTA’s future growth opportunities around 3P scale-up [third party] acquisition partnerships (Walmart, Instacart, etc.).” Oppenheimer reiterated Walmart as the top choice. The company said “the rally remains valid” for Walmart. “Based on our work, We are reiterating our Outperform rating and raising our PT to $90 from $81.”
